HomeCompareBPFH vs JNJ

BPFH vs JNJ: Dividend Comparison 2026

BPFH yields 36.61% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPFH wins by $162.2K in total portfolio value
10 years
BPFH
BPFH
● Live price
36.61%
Share price
$14.75
Annual div
$5.40
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$192.4K
Annual income
$30,193.06
Full BPFH calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BPFH vs JNJ

📍 BPFH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPFHJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPFH + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPFH pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPFH
Annual income on $10K today (after 15% tax)
$3,111.86/yr
After 10yr DRIP, annual income (after tax)
$25,664.10/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BPFH beats the other by $21,678.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPFH + JNJ for your $10,000?

BPFH: 50%JNJ: 50%
100% JNJ50/50100% BPFH
Portfolio after 10yr
$111.4K
Annual income
$17,441.23/yr
Blended yield
15.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BPFH
Analyst Ratings
1
Buy
11
Hold
Consensus: Hold
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPFH buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPFHJNJ
Forward yield36.61%2.13%
Annual dividend / share$5.40$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$192.4K$30.3K
Annual income after 10y$30,193.06$4,689.40
Total dividends collected$140.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BPFH vs JNJ ($10,000, DRIP)

YearBPFH PortfolioBPFH Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,361$3,661.02$10,592$272.30+$3.8KBPFH
2$20,280$4,913.64$11,289$357.73+$9.0KBPFH
3$28,184$6,484.86$12,123$472.89+$16.1KBPFH
4$38,580$8,422.85$13,141$629.86+$25.4KBPFH
5$52,056$10,775.32$14,408$846.81+$37.6KBPFH
6$69,288$13,587.96$16,021$1,151.60+$53.3KBPFH
7$91,041$16,902.73$18,122$1,588.22+$72.9KBPFH
8$118,170$20,756.38$20,930$2,228.20+$97.2KBPFH
9$151,621$25,179.03$24,792$3,191.91+$126.8KBPFH
10$192,428$30,193.06$30,274$4,689.40+$162.2KBPFH

BPFH vs JNJ: Complete Analysis 2026

BPFHStock

Boston Private Financial Holdings, Inc. operates as the bank holding company for Boston Private Bank & Trust Company that provides a range of banking products and services in the United States. It operates in two segments, Private Banking; and Wealth Management and Trust. The company offers deposit products, such as checking, savings and NOW, and money market accounts; and certificates of deposit. Its loan products include loans to individuals, such as residential mortgage loans, mortgage loans on investment or vacation properties, unsecured and secured personal lines of credits, home equity loans, and overdraft protection; and loans to businesses consisting of commercial and mortgage loans, revolving lines of credit, working capital loans, equipment financing, community lending programs, and construction and land loans. In addition, the company provides wealth management solutions comprising planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services to individuals, families, institutions, and nonprofit institutions. It operates offices in Boston, Miami, New York, Los Angeles, San Francisco, and Florida. Boston Private Financial Holdings, Inc. was founded in 1987 and is headquartered in Boston, Massachusetts.

Full BPFH Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BPFH vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPFH vs SCHDBPFH vs JEPIBPFH vs OBPFH vs KOBPFH vs MAINBPFH vs ABBVBPFH vs MRKBPFH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.